Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
USA Mutuals Vice Fund is a specialized mutual fund that invests primarily in industries considered to be 'vices,' including tobacco, alcoholic beverages, gaming, and aerospace and defense. Launched in 2002, the fund is built on the investment thesis that these sectors tend to be recession-resistant and possess high barriers to entry, often leading to consistent long-term performance. The fund was briefly renamed the Barrier Fund in 2014 before returning to its original name to better reflect its core strategy. It is managed by USA Mutuals and is accessible to investors through various share classes, including VICEX and VICVX. Although it is not a healthcare or biotechnology company, it represents a significant niche within the asset management industry by focusing on socially 'irresponsible' but historically profitable sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on USA Mutuals Vice Fund.